Cargando…

TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth

BACKGROUND: Multiple myeloma (MM) expands almost exclusively in the bone marrow and generates devastating bone lesions, in which bone formation is impaired and osteoclastic bone resorption is enhanced. TGF-β, a potent inhibitor of terminal osteoblast (OB) differentiation, is abundantly deposited in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeuchi, Kyoko, Abe, Masahiro, Hiasa, Masahiro, Oda, Asuka, Amou, Hiroe, Kido, Shinsuke, Harada, Takeshi, Tanaka, Osamu, Miki, Hirokazu, Nakamura, Shingen, Nakano, Ayako, Kagawa, Kumiko, Yata, Kenichiro, Ozaki, Shuji, Matsumoto, Toshio
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845613/ https://www.ncbi.nlm.nih.gov/pubmed/20360846 http://dx.doi.org/10.1371/journal.pone.0009870

Ejemplares similares

Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL
por: Kagawa, Kumiko, et al.
Publicado: (2012)

Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
por: Nakano, Ayako, et al.
Publicado: (2011)

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase
por: Harada, Takeshi, et al.
Publicado: (2022)

Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma
por: Ozaki, Shuji, et al.
Publicado: (2019)

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ
por: Iwasa, Masami, et al.
Publicado: (2019)

Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors
por: Harada, Takeshi, et al.
Publicado: (2013)

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
por: Teramachi, Jumpei, et al.
Publicado: (2020)

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
por: Hanson, Derek James, et al.
Publicado: (2015)

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
por: Ashtar, Mohannad, et al.
Publicado: (2020)

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
por: Amachi, Ryota, et al.
Publicado: (2016)

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
por: Bat-Erdene, Ariunzaya, et al.
Publicado: (2016)

Effective impairment of myeloma cells and their progenitors by hyperthermia
por: Miki, Hirokazu, et al.
Publicado: (2017)

Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis
por: Sumitani, Ryohei, et al.
Publicado: (2021)

Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava
por: Nakamura, Shingen, et al.
Publicado: (2017)

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma
por: Watanabe, Keiichiro, et al.
Publicado: (2021)

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma
por: Tanimoto, Kotaro, et al.
Publicado: (2021)

Magnetically Responsive Smart Nanoparticles for Cancer Treatment with a Combination of Magnetic Hyperthermia and Remote-Control Drug Release
por: Hayashi, Koichiro, et al.
Publicado: (2014)

Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
por: Hayashi, Koichiro, et al.
Publicado: (2013)

Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis
por: Dong, Bingzi, et al.
Publicado: (2022)

Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma
por: Oura, Masahiro, et al.
Publicado: (2023)

Mechanical Stress Activates Smad Pathway through PKCδ to Enhance Interleukin-11 Gene Transcription in Osteoblasts
por: Kido, Shinsuke, et al.
Publicado: (2010)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling
por: Harada, Takeshi, et al.
Publicado: (2021)

Comparison of Optical Coherence Tomography Angiography and Laser Speckle Flowgraphy for the Diagnosis of Normal-Tension Glaucoma
por: Takeyama, Asuka, et al.
Publicado: (2018)

The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease
por: Miki, Hirokazu, et al.
Publicado: (2022)

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression
por: Tenshin, Hirofumi, et al.
Publicado: (2022)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
por: Higa, Yoshiki, et al.
Publicado: (2023)

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
por: Nakaue, Emiko, et al.
Publicado: (2023)

Salmon DNA Accelerates Bone Regeneration by Inducing Osteoblast Migration
por: Sato, Ayako, et al.
Publicado: (2017)

Constitutional pericentric inversion of chromosome 16, inv(16)(p13.1q22), mimicking acute myeloid leukemia
por: Ozaki, Shuji, et al.
Publicado: (2022)

Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies
por: Tokunaga, Naoki, et al.
Publicado: (2016)

Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database
por: Handa, Hiroshi, et al.
Publicado: (2023)

Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma
por: Watanabe, Takashi, et al.
Publicado: (2015)

Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma
por: Yamashita, Michiko, et al.
Publicado: (2015)

Identification of a mammalian vesicular polyamine transporter
por: Hiasa, Miki, et al.
Publicado: (2014)

Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma
por: Kato, Masahiro, et al.
Publicado: (2003)

Targeted Therapy for HM1.24 (CD317) on Multiple Myeloma Cells
por: Harada, Takeshi, et al.
Publicado: (2014)

Correction of large jawbone defect in the mouse using immature osteoblast–like cells and a 3D polylactic acid scaffold
por: Suzuki, Shigeto, et al.
Publicado: (2022)

Signaling pathways regulating the specification and differentiation of the osteoblast lineage
por: Hojo, Hironori, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_btl26d3ratatsaudi5d9t1ihlf